Blue Biofuels (BIOF) 10-K/A 26 Apr 21 2020 FY Annual report (amended) Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 31, 2021	Jun. 30, 2020
Cover [Abstract]
Entity Registrant Name	ALLIANCE BIOENERGY PLUS, INC.
Entity Central Index Key	0001549145
Document Type	10-K/A
Amendment Flag	true
Amendment Description	Amendment No. 1
Current Fiscal Year End Date	--12-31
Document Period End Date	Dec. 31, 2020
Entity a Well-known Seasoned Issuer	No
Entity a Voluntary Filers	No
Entity Current Reporting Status	No
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 0
Entity Common Stock, Shares Outstanding		272,251,066
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 286,579	$ 110,630
Prepaid expenses	45,324	102,365
TOTAL CURRENT ASSETS	331,903	212,996
Other assets
Property and equipment, net of accumulated depreciation and amortization of $231,739 and $191,615, at December 31,2020, and December 31, 2019, respectively	247,431	140,365
Security deposits	30,276	30,276
Right of Use Assets, net of accumulated amortization	144,876	147,060
Patents	138,016	78,890
TOTAL OTHER ASSETS	560,599	396,591
TOTAL ASSETS	892,502	609,586
Current liabilities
Accounts payable	90,965	13,966
Accounts payable - Related Party	76,670	65,004
Deferred wages and director's fees - Related party	676,477	622,307
Lease Liability - Current	80,078	77,746
Convertible Debentures - Related Party	75,000
Interest Payable - Related Party	99,268
TOTAL CURRENT LIABILITIES	1,098,458	779,023
Long term liabilities
Right of Use Lease Liability, net of current portion	72,346	70,240
Paycheck Protection Program SBA loan	66,330
Convertible Debentures - Related Party		100,000
Chapter 11 Settlement	50,000	50,000
Notes Payable - Related Party	2,521,562	2,521,562
Notes Payable - Other	216,570	216,570
Convertible debenture, payable from future profits - Related Party	204,000	204,000
TOTAL LONG TERM LIABILITIES	3,130,808	3,162,372
TOTAL LIABILITIES	4,229,266	3,941,395
STOCKHOLDERS' EQUITY
Preferred stock; $0.001 par value; 10,000,000 shares authorized; zero shares issued and outstanding
Common stock; $0.001 par value; 500,000,000 shares authorized; 241,721,947 shares issued and outstanding at December 31, 2020, and 219,513,233 shares issued and outstanding at December 31, 2019.	241,722	219,513
Additional paid-in capital	43,103,607	40,949,645
Accumulated deficit	(6,682,093)	(44,500,966)
Total stockholders' equity	(3,336,764)	(3,331,808)
TOTAL EQUITY (DEFICIT)	(3,336,764)	(3,331,808)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 892,502	$ 609,586

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Accumulated depreciation and amortization on property and equipment	$ 231,739	$ 191,615
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	241,721,947	219,513,233
Common stock, shares outstanding	241,721,947	219,513,233

Consolidated Statement of Opera

Consolidated Statement of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenues		$ 60,000
Operating expense:
General and administrative	1,227,776	1,038,814
Research & Development	763,159	797,862
Total operating expenses	1,990,935	1,836,676
Loss from operations:	(1,990,935)	(1,776,676)
Other (income) expense:
Loss (Gain) on extinguishment of debt		(2,125,250)
Loss (Gain) in change of fair value of derivative liability		(656,533)
Interest expense - related party	177,875
Interest expense - other	12,317
Total other (income) expense	190,192	(2,781,783)
Income (Loss) before provisions for income taxes	(2,181,127)	1,005,107
Provisions for income taxes
Net Income / (Loss):	$ (2,181,127)	$ 1,005,107
Net income (loss) per share	$ (0.009)	$ 0.01
Weighted average common shares outstanding
Basic and Diluted	229,878,617	166,070,036

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2018	$ 140,240		$ 39,178,390	$ (45,506,073)	$ (6,187,443)
Balance, shares at Dec. 31, 2018	140,240,398
Issuance of common stock for services	$ 1,936		66,536		$ 68,472
Issuance of common stock for services, shares	1,936,450				1,936,450
Issuance of 2,425,000 warrants for services			120,084		$ 120,084
Issuance of common stock for cash	$ 57,800		231,200		289,000
Issuance of common stock for cash, shares	57,800,000
Issuance of common stock and warrants for cash through PPM	$ 19,436		915,383		934,819
Issuance of common stock and warrants for cash through PPM, shares	19,436,385
Issuance of common stock in exchange for debt	$ 100		4,900		5,000
Issuance of common stock in exchange for debt, shares	100,000
Issuance of options under the employee, director plan			220,299		220,299
Issuance of common stock as per Chapter 11 Plan Confirmation			212,853		212,853
Net Income (Loss)				1,005,107	1,005,107
Balance at Dec. 31, 2019	$ 219,513		40,949,645	(44,500,966)	(3,331,808)
Balance, shares at Dec. 31, 2019	219,513,233
Issuance of common stock for services	$ 733		36,767		$ 37,500
Issuance of common stock for services, shares	733,130				733,130
Issuance of common stock for cash					$ 887,380
Issuance of common stock for cash, shares					13,558,462
Issuance of common stock and warrants for cash through PPM	$ 13,558		873,822		$ 887,380
Issuance of common stock and warrants for cash through PPM, shares	13,558,462
Issuance of common stock in exchange for debt	$ 1,000		24,000		25,000
Issuance of common stock in exchange for debt, shares	1,000,000
Warrants exercised	$ 6,639		343,361		350,000
Warrants exercised, shares	6,639,344
Cashless exercise of stock options	$ 278		(278)		0
Cashless exercise of stock options, shares	277,778
Issuance of 11,000,000 options under the employee, director plan			876,291		876,291
Net Income (Loss)				(2,181,127)	(2,181,127)
Balance at Dec. 31, 2020	$ 241,722		$ 43,103,607	$ (46,682,093)	$ (3,336,764)
Balance, shares at Dec. 31, 2020	241,721,947

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Parenthetical) - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Statement of Stockholders' Equity [Abstract]
Warrants issued for service		2,425,000
Options issued under the employee director plan	11,000,000	8,900,000
Warrants issued for settlement of notes payable		8,500,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net Income (Loss)	$ (2,181,127)	$ 1,005,107
Reconciliation of net loss to net cash used in operating activities
Depreciation and amortization	40,124	31,380
Extinguishment of debt		(2,125,250)
Change in fair value of embedded derivative		(656,533)
Stock based compensation for services	37,500	68,472
Net issuance of options & warrants	876,291	553,237
Changes in operating assets and liabilities
Prepaid expenses	57,041	(100,530)
Accrued interest - related party	99,268
Accounts payable and accrued liabilities	142,835	83,819
Unearned Income		(60,000)
Right of use lease	6,622	926
Net cash used in operating activities	(921,446)	(1,199,373)
Cash flows from investing activities
Purchase of property and equipment	(147,189)	(17,279)
Security deposits		(22,376)
Patent Costs	(59,126)	(78,890)
Net cash from (used in) investing activities	(206,315)	(118,545)
Cash flows from financing activities
Proceeds from long-term note payable - other	66,330
Proceeds from convertible debt - related party		100,000
Proceeds from exercise of warrants	350,000
Net proceeds from issuance of common stock	887,380	1,223,819
Net cash provided by financing activities	1,303,710	1,323,819
Net increase (decrease) in cash and cash equivalents	175,949	5,901
Cash and cash equivalent at beginning of the period	110,630	104,728
Cash and cash equivalent at end of the period	286,579	110,630
Cash paid during the period for
Interest
Taxes
Supplemental schedule of non-cash activities
Cashless conversion of warrants/options
Conversion of convertible debenture to common stock	$ 25,000

Organization

Organization	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	NOTE 1 – ORGANIZATION Alliance Bioenergy Plus, Inc (the “Company”) is a technology company focused on emerging technologies in the renewable energy, biofuels, and new technologies sectors. In January 2018, the Company’s technology experts developed a new technology system it calls Cellulose-to-Sugar 2.0 or CTS 2.0, and a patent application was filed. The 100% owned CTS 2.0 is a mechanical/chemical dry process for converting cellulose material into sugar for use in the biofuels industry. CTS 2.0 can convert any cellulosic material – like grasses, wood, paper, farm waste, yard waste, forestry products, energy crops like hemp or King Grass, and the cellulosic portion of municipal solid waste – into sugars and lignin, and subsequently into biofuels and bioplastics. The CTS 2.0 system produces sugar and chemically unmodified lignin among other by-products. The sugar can then be further converted into biofuels and the lignin into bioplastics. The new technology made it worthwhile to financially restructure the Company through Chapter 11. The Company voluntarily filed for Chapter 11 on October 22, 2018, in the U.S. Bankruptcy Court in the Southern District of Florida. The Company exited Chapter 11 on September 18, 2019, while keeping all classes, including shareholders, unimpaired. The bankruptcy case was closed on October 25, 2019. Fresh Start accounting is not being applied because existing voting shares immediately before Plan Confirmation were not less than 50 percent of the voting shares of the emerging entity. The Company’s focus is to commercialize its wholly owned CTS 2.0 technology. The Company is currently working with its 4 th th Plan of Operation The Company is now doing the engineering work to commercialize its 100% owned CTS 2.0 technology. The Company has a strategy that includes the following: 1) Selling sugar or ethanol either direct or in combination with joint ventures, mergers, and/or acquisitions of existing businesses in the renewable energy space; 2) Selling low-cost high purity lignin, or using that lignin to produce biodegradable plastics, or making biodegradable bioplastics products and selling them under our own brand.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern, which assumes the Company will realize its assets and discharge its liabilities in the normal course of business. The Company has not generated any significant revenue since inception and has incurred losses since inception. As of December 31, 2020, the Company has a working capital deficiency of $766,555. As of December 31, 2020, the Company has incurred accumulated losses of $46,682,093. On October 22, 2018, the Company filed for Chapter 11 bankruptcy. On September 18, 2019, the judge confirmed the Company’s Chapter 11 Plan, and on October 25, 2019, the bankruptcy case was closed. The Company expects to incur significant additional losses and liabilities in connection with its start-up and commercialization activities. The Company’s ability to continue as a going concern is dependent upon its ability to obtain the necessary financing to meet its obligations and repay its liabilities when they become due and to generate sufficient revenues from its operations to pay its operating expenses. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments related to the recoverability and classifications of recorded asset amounts, or amounts and classifications of liabilities that might result from this uncertainty. There are no assurances that the Company will continue as a going concern. Management believes that the Company’s future success is dependent upon its ability to achieve profitable operations, generate cash from operating activities and obtain additional financing. There is no assurance that the Company will be able to generate sufficient cash from operations, sell additional shares of stock or borrow additional funds. The Company’s inability to obtain additional cash could have a material adverse effect on its financial position, results of operations, and its ability to continue in existence. These financial statements do not include any adjustments that might result from the outcome of this uncertainty The Company intends to raise additional capital and continue engineering work and scaling up towards a full-scale commercial size CTS 2.0 modular unit. At that point, and to minimize dilution to shareholders, the Company will seek project-based financing to build (or acquire and retrofit) or joint venture with existing ethanol producers to produce cellulosic ethanol and lignin/bioplastics from its patented CTS 2.0 system. Once the first plant is profitable, the Company intends to grow with additional plants both in the United States and internationally. Currently, the US government gives a D3 RIN to incentivize the production of renewable fuels from cellulosic materials. The value of the D3 RIN fluctuates, but as of this filing, it is around $2.60 per gallon of ethanol on top of the market price of ethanol. The Company believes that its CTS 2.0 process can produce ethanol profitably at the market price, and with the D3 RIN should generate substantial profits and cash flow in amounts sufficient to cover the Company’s operating expenses and debt service. Our business, results of operations, and financial condition may be adversely impacted by the COVID-19 pandemic The COVID-19 pandemic has negatively affected the U.S. and global economies, disrupted global supply chains, resulted in significant travel and transport restrictions, including mandated closures and orders to “shelter-in-place,” and created significant disruption of the financial markets. We are closely monitoring the impact of the COVID-19 pandemic on all aspects of our business, including how it will impact our customers, employees and supply chain. Given the critical nature of the products that we provide, our office and lab have remained open during the pandemic. The extent to which our operations may be impacted by the COVID-19 pandemic will depend largely on future developments, which are highly uncertain and cannot be accurately predicted. We may experience additional operating costs due to increased challenges with our workforce (including as a result of illness, absenteeism or government orders), access to supplies, capital, and fundamental support services (such as shipping and transportation). Even after the COVID-19 pandemic has subsided, we may experience materially adverse impacts to our business due to any resulting economic recession or depression. Furthermore, the impacts of a potential worsening of global economic conditions and the continued disruptions to and volatility in the financial markets remain unknown.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of the Company’s majority-owned subsidiaries over which the Company exercises control. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries, after elimination of intercompany accounts and transactions. Investments in business entities in which the Company lacks control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. All material intercompany transactions and balances were eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates presented and reported amounts of revenues and expenses during the reporting periods presented. Significant estimates inherent in the preparation of the accompanying Consolidated Financial Statements include estimates of impairment assessment of identifiable intangible assets and valuation allowance for deferred tax assets. Estimates are based on past experience and other considerations reasonable under the circumstances. Actual results may differ from these estimates. Cash and Cash Equivalents All highly liquid investments with maturities of three months or less at the date of purchase are considered to be cash equivalents. Stock Compensation The Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the provisions of ASC Topic 718, “Stock Compensation” (formerly referred to as SFAS No. 123(R)). Share-based payments to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, ASC Topic 505, “Equity Payments to Non-Employees” or other applicable authoritative guidance. Stock-based Compensation Valuation Methodology Stock-based compensation resulting from the issuance of common stock is calculated by reference to the valuation of the stock on the date of issuance, the expense being recognized as the compensation is earned. Stock-based compensation expenses related to employee options and warrants granted to non-employees are recognized as the stock options and warrants are earned. The fair value of the stock options or warrants granted is estimated at the grant date, using the Black-Scholes option-pricing model, and the expense is recognized on a straight-line basis over the shorter of the period over which services are to be received or the life of the option or warrant. The grant date fair value of employee share options and similar instruments is estimated using the Black-Scholes option-pricing model on the basis of the fair value of the underlying common stock on the measurement date, adjusted for the unique characteristics of those equity instruments, using the assumptions noted in the table below. The fair value of the common stock is determined by the then-prevailing closing market price. Expected volatility was based on the historical volatility of the Company’s closing day market price per share. The expected term of options and warrants was based upon the life of the option, and the risk-free rate used was based on the U.S. Treasury Daily Yield Curve Rate. The stock compensation issued for services during the years ended December 31, 2020, and December 31, 2019, were valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the years ended December 31, 2020, and December 31, 2019: 2/25/19 3/22/19 5/1/19 5/23/19 5/30/19 7/23/19 7/31/19 Risk-free interest rate 2.48 % 2.24 % 2.52 % 2.31 % 2.03 % 1.83 % 1.84 % Expected life 5 years 5 years 10 years 10 years 5 years 5 years 5 years Expected dividends 0 % 0 % 0 % 0 % 0 % 0 % 0 % Expected volatility 217.76 % 221.85 % 223.38 % 188.70 % 224.24 % 230.08 % 230.30 % ALLM common stock fair value $ 0.020 $ 0.025 $ 0.040 $ 0.050 $ 0.037 $ 0.050 $ 0.050 1/9/20 2/18/20 5/8/20 11/6/20 11/12/20 Risk-free interest rate 1.65 % 1.39 % 0.69 % 0.36 % 0.40 % Expected life 5 years 5 years 10 years 5 years 5 years Expected dividends 0 % 0 % 0 % 0 % 0 % Expected volatility 229.32 % 228.60 % 226.42 % 212.00 % 213.22 % ALLM common stock fair value $ 0.058 $ 0.065 $ 0.083 $ 0.071 $ 0.080 Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets, generally 5 to 10 years. Expenditures for additions and improvements are capitalized; repairs and maintenance are expensed as incurred. Patent Capitalization If a product is currently under research and development and is not currently approved for market, costs incurred in connection with patent applications should generally be expensed in the income statement because there is uncertainty as to the future economic benefit of the asset. Conversely, if a product is approved for market (as is the case of the end product ethanol), or if future economic benefit is probable, or if an alternative future use is available to the Company, then such patent costs can be capitalized and amortized over the expected life of the patent(s). Since the Company’s primary end product is sugar converting to ethanol, which are in wide use, the Company has determined that it is reasonable to capitalize the patent costs associated with its CTS process. Research and Development The Company expenses all research and development costs as incurred. For the years ended December 31, 2020, and December 31, 2019, the amounts charged to research and development expenses were $763,159 and $797,862, respectively. Revenue Recognition The Company follows FASB ASC 605 “Revenue Recognition” and recognizes revenue when it is realized or realizable and earned. The Company’s revenues will be derived principally from joint ventures, royalties and eventually corporate owned plants. However, no sales have occurred through those revenue streams to date. The Company considers revenue realized or realizable and earned when all of the following criteria are met: 1. persuasive evidence of an arrangement exists; 2. the product has been shipped or the services have been rendered to the customer; 3. the sales price is fixed or determinable; and, 4. collectability is reasonably assured. Convertible Instruments The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”. Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments (when we have determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption. Accounting for Derivative Instruments The Company issues debentures where the number of shares into which a debenture can be converted is not fixed. For example, when a debenture converts at a discount to market based on the stock price on the date of conversion. In such instances, the embedded conversion option of the convertible debentures is bifurcated from the host contract and recorded at their fair value. In accounting for derivatives, the Company records a liability representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount representing the imputed interest associated with the beneficial conversion feature. The discount is then amortized over the life of the debenture and the derivative liability is adjusted periodically according to stock price fluctuations. At the time of conversion, any remaining derivative liability is charged to additional paid-in capital. For purposes of determining derivative liability, the Company uses Black-Scholes modeling for computing historic volatility. Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. Non-controlling interest in consolidated subsidiaries The accompanying consolidated financial statements include the accounts of Alliance BioEnergy Plus, Inc. and those subsidiaries that the Company has the ability to control either through voting rights or means other than voting rights. For these subsidiaries, the Company records 100% of the revenues, expenses, cash flows, assets and liabilities in its consolidated financial statements. For subsidiaries that the Company controls but hold less than 100% ownership, a non-controlling interest is recorded in the consolidated income statement to reflect the non-controlling interest’s share of the net income (loss), and a non-controlling interest is recorded in the consolidated balance sheet to reflect the non-controlling interest’s share of the net assets of the subsidiary. As of the date of this filing, the Company has no subsidiaries. Investments in non-consolidated affiliates Investments in non-consolidated affiliates are accounted for using the equity method or cost basis depending upon the level of ownership and/or the Company’s ability to exercise significant influence over the operating and financial policies of the investee. When the equity method is used, investments are recorded at original cost and adjusted periodically to recognize the Company’s proportionate share of the investees’ net income or losses after the date of investment. When net losses from an investment are accounted for under the equity method exceed its carrying amount, the investment balance is reduced to zero and additional losses are not provided for. The Company resumes accounting for the investment under the equity method if the entity subsequently reports net income and the Company’s share of that net income exceeds the share of net losses not recognized during the period the equity method was suspended. Investments are written down only when there is clear evidence that a decline in value that is other than temporary has occurred. The Company monitors its investment for impairment at least annually and makes appropriate reductions in the carrying value if it determines that an impairment charge is required based on qualitative and quantitative information. As of the date of this filing, the Company has no investments in non-consolidated affiliates. Impairment of Long Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable, the Company compares the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected to be generated by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the carrying value, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less costs to sell. Income Taxes The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized. ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions for any of the reporting periods presented. Profit (Loss) per Common Share: Basic profit (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially dilutive effect of securities such as outstanding options and warrants. The computation of potential common shares has been performed using the treasury stock method. The warrants and options are antidilutive for all periods presented. When net loss is reported, diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive. Fair Value Measurements The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions) For the years ended December 31, 2020, and December 31, 2019, the Company recognized a gain of $0 and a gain of $656,533, respectively, on the change in fair value of its derivative liabilities. At December 31, 2020, the Company did not identify any assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with ASC 825-10. Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.

Assets

Assets	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Assets	NOTE 4 – ASSETS Patents The Company has applied for two patents on its technology, and has also applied for international patents. The Company has capitalized the legal and filing fees in the amount of $138,016.

Debt

Debt	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Debt	NOTE 5 – DEBT Details of each debt, including those that have been paid off or renegotiated during 2018 or 2019, are indicated below. Convertible Debentures Related Party On March 12, 2019, the Company entered into a convertible promissory note with Edmund J Burke for a total of $25,000. The note is due on March 12, 2021, and carries no interest. To the extent unpaid five years after September 18, 2019, it is discharged. At the option of the noteholder, the note is convertible into common stock at $0.025/share. On January 22, 2021, Edmund Burke elected to convert this Note into common stock. On March 12, 2019, the Company entered into a convertible promissory note with Chris Jemapete for a total of $25,000. The note is due on March 12, 2021, and carries no interest. To the extent unpaid five years after September 18, 2019, it is discharged. At the option of the noteholder, the note is convertible into common stock at $0.025/share. On August 5, 2020, Chris Jemapete elected to convert the note into common stock. On March 12, 2019, the Company entered into a convertible promissory note with AES Capital Partners, LP, for a total of $50,000. The note is due on March 12, 2021, and bears 15% interest. To the extent unpaid five years after September 18, 2019, it is discharged. At the option of the noteholder, the note is convertible into common stock at $0.025/share. Upon conversion, all interest shall be forgiven. On January 22, 2021, AES Capital Partners, LP, elected to convert this Note into common stock. Paycheck Protection Program SBA Loan In May 2020, the Company received a loan in the amount of $66,330 under the Payroll Protection Program (“PPP Loan”). The loan accrues interest at a rate of 1% and has an original maturity date of two years which can be extended to five years by mutual agreement of the Company and SBA. The PPP loan contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. Under the terms of the loan, a portion or all of the loan is forgivable to the extent the loan proceeds are used to fund qualifying payroll, rent and utilities during a designated twenty-four week period. Payments are deferred until the SBA determines the amount to be forgiven. The Company has utilized the proceeds of the PPP loan in a manner which will enable qualification as a forgivable loan. However, no assurance can be provided that all or any portion of the PPP loan will be forgiven. The balance on this PPP loan was $66,330 as of December 31, 2020 and has been classified as a long-term liability in notes payable. Notes Payable — Chapter 11 Settlement On July 18, 2018, the Company’s former Controller Dennis Lenaburg sued the Company for $2,694,577 dollars plus stock warrants in the Circuit Court of the 15 th Notes Payable – Related Parties In July 2016, the Company issued six (6) short-term notes payable to related parties in conjunction with the Company’s acquisition of the remaining 49% of AMG Energy Group. These notes had a value of $2,002,126 and accrued interest at a rate of six percent (6%) per annum. As of December 31, 2018, and December 31, 2017, the total interest accrued on the notes was $278,794.68 and $176,460 respectively. All of the notes were due on August 4, 2017 and then were in default. However, the notes were held by related parties with the understanding that the notes were not to be paid until the Company begins generating profit. The Company renegotiated some of these notes during its Chapter 11 proceedings, whereas others failed to submit a claim and were discharged upon the Court’s Confirmation Order approving the Company’s Chapter 11 Plan on September 18, 2019. The renegotiated amounts, as per the Plan Confirmation are all to be paid from 50% of the future net profits and discharged to the extent unpaid five years after the Plan effective date of September 18, 2019. These amount are 1) Mark Koch $240,990 plus 6% interest on any portion not repaid within 12 months of the Company’s first reported quarterly net profit; 2) Animated Family Films $579,942 out of the Company’s net profits plus 6% interest; 3) Steven Dunkle, CTWC, & Wellington Asset Holdings $1.5 million plus 6% interest once there is positive quarterly EBITDA from the first plant of Company, or, at its option, may convert that into an equity investment in the first plant of the Company, measured by a percentage of the total cost to build, subject to a minimum equity interest of 1.25% in said plant. On February 28, 2018, the Company entered into a short-term loan with Steven Sadaka, with a principal balance of $100,000 due and payable on May 1, 2018. The note does not accrue interest, however the Company provided 2,000,000 inducement shares to secure the note. These inducement shares were valued at $84,000 and are being amortized over the life of the note. The note’s maturity date was extended to 7/1/2018. If the note is not repaid at maturity, then an additional 5,000,000 shares of common stock will be due. The note was renegotiated during the Company’s Chapter 11 proceedings, and as per the Plan Confirmation, it is agreed that $100,000 is to be paid out of future gross revenues to satisfy this note in full, with no additional shares to be issued. On May 15, 2018, the Company entered into a short term loan with Christopher Jemapete, with a principal balance of $50,000 due and payable on May 16, 2019. The note carried an interest rate of 5% plus the company issued 1,250,000 inducement shares to secure the note as well as 1,000,000 warrants with a $0.10 strike price and with a 5-year expiration. These inducement shares were valued at $36,250 and are being amortized over the life of the note; the warrants had a value of $24,449. On August 25, 2018, this note was restructured to remove the warrants. As of June 30, 2018 accrued interest on this note is $315. The note was renegotiated during the Company’s Chapter 11 proceedings, and as per the Plan Confirmation, it is agreed that $50,315.07 is to be paid out of future gross revenues. On May 15, 2018, the Company entered into a short term loan with Pamela Jemapete, with a principal balance of $50,000 due and payable on May 16, 2019. The note carried an interest rate of 5% plus the company issued 1,250,000 inducement shares to secure the note as well as 1,000,000 warrants with a $0.10 strike price and with a 5-year expiration. These inducement shares were valued at $36,250 and are being amortized over the life of the note; the warrants had a value of $24,449. On August 25, 2018, this note was restructured to remove the warrants. As of June 30, 2018 accrued interest on this note is $315. The note was renegotiated during the Company’s Chapter 11 proceedings, and as per the Plan Confirmation, it is agreed that $50,315.07 is to be paid out of future gross revenues. Notes Payable – Other In July 2016, the Company issued a short-term note payable to a third party in conjunction with the Company’s acquisition of the remaining 49% of AMG Energy Group. The note had a principal balance of $96,570 and accrued interest at a rate of six percent (6%) per annum. As of December 31, 2018, and December 31, 2017, the total interest accrued on the note was $14,382.2 and $8,588 respectively. The note was due on August 4, 2017 and was then in default. The Company renegotiated this note during its Chapter 11 proceedings, and as per the Plan Confirmation, now the $96,570 is to be paid with no interest out of the same 50% of the future net profits of the Company as the notes mentioned above, if any, or discharged to the extent unpaid five years after September 18, 2019. In November 2017, the Company entered into a convertible debenture with Lucas Hoppel, with a principal balance of $143,000 due and payable on May 30, 2018. The note carries an 8% one-time interest charge, a $43,000 original issue discount and a 35% conversion discount to the lowest trade price in the prior twenty-five trading days, after 180 days, in whole or in part at the option of the holder. In addition, the Company provided 500,000 inducement shares to secure the note, and may have to provide additional shares on the note’s 6-month anniversary if the Company’s share price declines. These inducement shares were valued at $39,500 and were amortized over the life of the note. The note can be repaid, without prepayment penalties, within the first 90 days. Thereafter, the note will incur a 120% prepayment penalty of the then outstanding principal and interest due. In May 2018, the company made two principal payments totaling $40,000. The note went into default on June 1, 2018 and incurred a 40% penalty of the outstanding balance immediately prior to the default event. On August 30, 2018, Hoppel sued the Company in Superior Court of the State of California County of San Diego Central District. That case was staid on October 22, 2018 when the Company filed for Chapter 11 protection in the US Bankruptcy Court in the Southern District of Florida. Negotiations took place and a settlement was reached on this note and a subsequent note, and confirmed as part of the Plan Confirmation Order, that Hoppel would be paid a total of $100,000 out of 5% of the future gross revenue of the Company. In February 2018, the Company entered into a convertible debenture with Lucas Hoppel, with a principal balance of $165,000 due and payable on September 21, 2018. The note carries an 8% one-time interest charge, a $15,000 original issue discount and a 40% conversion discount to the lowest trade price in the prior twenty-five trading days, after 180 days, in whole or in part at the option of the holder. In addition, the Company provided 500,000 inducement shares to secure the note. These inducement shares were valued at $14,500, and were amortized over the life of the note. The note can be repaid, without prepayment penalties, within the first 90 days. Thereafter, the note will incur a 120% prepayment penalty of the then outstanding principal and interest due. The Note went into default on June 1, 2018, through a cross default provision with another Note to Hoppel, and incurred a 40% penalty of the outstanding balance immediately prior to the default event. On August 30, 2018, Hoppel sued the Company in Superior Court of the State of California County of San Diego Central District. That case was staid on October 22, 2018 when the Company filed for Chapter 11 protection in the US Bankruptcy Court in the Southern District of Florida. Negotiations took place and a settlement was reached on this note and a prior note, and confirmed as part of the Plan Confirmation Order, that Hoppel would be paid a total of $100,000 out of 5% of the future gross revenue of the Company to settle both notes. On March 27, 2019, the Company entered into an agreement with Partiz and Company, P.A. such that its debt will be reduced from $32,000 to $20,000 payable out of future gross revenues, upon the bankruptcy court’s acceptance of the Company’s plan of reorganization. The Plan was confirmed by the Court on September 18, 2019. Convertible Debentures – Related Parties On November 8, 2018, the Company entered into a convertible promissory note with Edmund J Burke for a total of $175,000. There is no interest, and it is payable out of 20% of the net profits of Company. The note is convertible into common stock at $0.05/share. Upon conversion, Burke shall receive an additional 4,450,148 warrants at a strike price of $0.005/share that expire on November 8, 2023. In addition, 4,450,148 shares of Burke’s common stock was cancelled. On January 22, 2021, Edmund Burke elected to convert this Note into common stock. On November 8, 2018, the Company entered into a convertible promissory note with Steven Sadaka for a total of $24,000. There is no interest, and it is payable out of 2.5% of the net profits of Company. The note is convertible into common stock at $0.05/share. Upon conversion, Sadaka shall receive an additional 1,000,000 warrants at a strike price of $0.005/share that expire on November 8, 2023. In addition, 1,000,000 shares of Sadaka’s common stock was cancelled. On January 15, 2021, Steven Sadaka elected to convert this Note into common stock. On November 8, 2018, the Company entered into a convertible promissory note with Annie Bindler for a total of $2,500. There is no interest, and it is payable out of 0.5% of the net profits of Company. The note is convertible into common stock at $0.05/share. Upon conversion, Annie Bindler shall receive an additional 100,000 warrants at a strike price of $0.005/share that expire on November 8, 2023. In addition, 100,000 shares of Annie Bindler’s common stock was cancelled. On January 13, 2021, Annie Bindler elected to convert this Note into common stock. On November 8, 2018, the Company entered into a convertible promissory note with Zac Bindler for a total of $2,500. There is no interest, and it is payable out of 0.5% of the net profits of Company. The note is convertible into common stock at $0.05/share. Upon conversion, Zac Bindler shall receive an additional 100,000 warrants at a strike price of $0.005/share that expire on November 8, 2023. In addition, 100,000 shares of Zac Bindler’s common stock was cancelled. On January 13, 2021, Zac Bindler elected to convert this Note into common stock. A summary of all debts indicated in the Notes above is as follows: Notes Payable December 31, 2020 December 31, 2019 Short Term Notes Payable - Related Party $ - $ Short Term Convertible Debentures Related Party $ 75,000 $ Long Term Chapter 11 Settlement $ 50,000 $ 50,000 Long Term Paycheck Protection Program SBA loan $ 66,330 $ Long Term Notes Payable from future revenue — Related Party $ 1,700,630 $ 1,700,630 Long Term Notes Payable from future revenue — Other $ 120,000 $ 120,000 Long Term Note Payable from future profits — Related Party $ 820,932 $ 820,932 Long Term Note Payable from future profits — Other $ 96,570 $ 96,570 Long Term Convertible Debentures — Related Party $ 204,000 $ 304,000 TOTAL NOTES $ 3,133,462 $ 3,092,132 $100,000 of the amount listed under Long Term Convertible Debentures in the summary chart for 2019 were short term as of the end of 2020. Of the $3,133,462 due as of December 31, 2020, $1,820,630 is due out of future revenue and $917,502 is due out of future profits, totaling $2,738,132. $2,417,502 of that debt will be discharged if not paid by September 18, 2024, which is 5 years after the Company exited Chapter 11. $66,330 may be forgiven by the SBA. The remaining debt that would not be discharged or forgiven, and which has not converted as of the date of this filing, is $170,000, consisting of $120,000 due out of future revenue to other, and a $50,000 Chapter 11 settlement.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Stockholders' Equity	NOTE 6 – STOCKHOLDERS’ EQUITY The total number of shares of capital stock, which the Company has authority to issue, is 510 million, 500 million of which are designated as common stock at $0.001 par value (the “Common Stock”) and 10 million of which are designated as preferred stock par value $0.001 (the “Preferred Stock”). As of December 31, 2020, the Company had 241,721,947 shares of Common Stock issued and outstanding and no shares of Preferred Stock were issued. Holders of shares of Common stock shall be entitled to cast one vote for each share held at all stockholders’ meetings for all purposes, including the election of directors. The Common Stock does not have cumulative voting rights. No holder of shares of stock of any class shall be entitled as a matter of right to subscribe for or purchase or receive any part of any new or additional issue of shares of stock of any class, or of securities convertible into shares of stock of any class, whether now hereafter authorized or whether issued for money, for consideration other than money, or by way of dividend. The Company has yet to designate any rights, preferences and privileges for any of its authorized Preferred Stock. In the year ended December 31, 2019, the Company issued an aggregate of 1,936,450 shares of its common stock for services valued at $68,472. In the year ended December 31, 2019, the Company issued an aggregate of 2,425,000 warrants for services. Using a Black-Scholes asset-pricing model, these warrants were valued at $120,084. These warrant agreements have terms of five years with exercise prices of $0.05 per share. In the year ended December 31, 2019, 500,000 warrants expired. In the year ended December 31, 2019, the Company issued an aggregate of 57,800,000 shares of common stock to management and directors. These were valued at $289,000. In the year ended December 31, 2019, the Company issued an aggregate of 19,436,385 shares of common stock for cash through private placements for $934,819. In the year ended December 31, 2019, the Company issued an aggregate of 100,000 shares of common stock for debt. These were valued at $5000. In the year ended December 31, 2019, the Company issued an aggregate of 8,900,000 options under the employee stock option plan. These were valued at $220,299. The Company also rescinded 49,275,157 options issued under the employee stock option plan. In the year ended December 31, 2019, the Company issued an aggregate of 8,500,000 warrants as per Chapter 11 Settlement Agreements. Using a Black-Scholes asset-pricing model, these totaled to $212,853. In the year ended December 31, 2020, the company issued an aggregate of 733,130 shares of its common stock for services, valued at $37,500. In the year ended December 31, 2020, the Company did not issue any warrants for services. In the year ended December 31, 2020, 6,639,344 warrants were exercised at an average price of 5.3 cents for total proceeds of $350,000. In the year ended December 31, 2020, 9,155,656 warrants and options expired. In the year ended December 31, 2020, 500,000 employee stock options were exercised using the cashless exercise provision to obtain 277,778 shares. In the year ended December 31, 2020, the Company issued 13,558,462 common shares for cash of $887,380. In the year ended December 31, 2020, $25,000 of convertible notes issued during Chapter 11 to a related party converted into 1,000,000 shares of common stock. In the year ended December 31, 2020, the Company issued options under its Employee & Directors Stock Option Plan to purchase an aggregate of 11,000,000 shares of common stock for a period of five to ten years at an exercise price ranging from $0.042 to $0.10. Using a Black-Scholes asset-pricing model, these agreements were valued at $876,291. An additional 10,550,000 unvested options were issued. Share-Based Awards Stock option activity under the 2012 ESOP for the year ending December 31, 2020, is as follows: Option Shares Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value ($0’s) Outstanding as of December 31, 2019 5,807,099 $ 0.08 6.43 $ 445,815 Awarded 21,550,000 $ 0.10 9.17 $ 2,108,000 Exercised 500,000 $ 0.05 - $ 25,000 Expired 2,900,000 $ 0.09 - $ 257,250 Outstanding as of December 31, 2020 23,957,099 $ 0.09 8.64 $ 2,271,565 Vested as of December 31, 2020 12,707,099 $ 0.09 8.22 $ 1,186,565 Warrant activity for the year ending December 31, 2020, is as follows: Warrants Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value ($0’s) Outstanding as of December 31, 2019 42,002,390 $ 0.28 3.16 $ 11,693,720 Issued 19,533,333 $ 0.11 0.53 $ 2,180,000 Exercised 6,639,344 $ 0.05 - $ 350,000 Expired 6,255,656 $ 0.09 - $ 554,920 Outstanding as of December 31, 2020 48,640,723 $ 0.23 2.09 $ 11,178,470 Vested as of December 31, 2020 48,640,723 $ 0.23 2.09 $ 11,178,470

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 7 – INCOME TAXES The reconciliation of income tax benefit at the U.S. statutory rate of 21% for years ending December 31, 2020, and 2019, to the Company’s effective tax rate, is as follows: December 31, 2020 December 31, 2019 Statutory federal income tax rate -21 % -21 % State income tax, net of federal benefits -4.46 % -4.46 % Valuation Allowance 25.46 % 25.46 % Income tax provision (benefit) 0 % 0 % The provisional (benefit) for income tax is summarized as follows: December 31, 2020 December 31, 2019 Federal Current - - Deferred $ (458,037 ) $ 211,072 State Current - Deferred $ (97,278 ) $ 44,828 Change in valuation allowance 588,904 (255,900 ) Income tax provision (benefit) - - The tax effects of temporary differences that give rise to the Company’s net deferred tax liability as of December 31, 2020 and 2019 are as follows: Years Ended December 31, 2020 December 31, 2019 Deferred tax asset Net operating loss carryovers $ 10,662,231 $ 10,106,916 Total deferred tax assets 10,662,231 10,106,916 Valuation Allowance (10,662,231 ) (10,106,916 ) Deferred tax asset, net of allowance $ - $ - As of December 31, 2020, and 2019, the Company had approximately $41,878,363, and $39,697,236 of Federal net operating loss carryovers (“NOLs”) to offset taxable income, if any, in future years which begin to expire in 2033. Utilization of the NOLs may be subject to limitation under the Internal Revenue Code Section 382 should there be a greater than 50% ownership change as determined under regulations. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against the entire deferred tax asset relating to NOLs for every period because it is more likely than not that all of the deferred tax asset will not be realized. On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (the “Tax Act”) was signed into law making significant changes to the Internal Revenue Code. Changes include, but are not limited to, a federal corporate tax rate decrease from 35% to 21% for tax years beginning after December 31, 2017, the transition of U.S international taxation from a worldwide tax system to a territorial system, and a one-time transition tax on the mandatory deemed repatriation of foreign earnings. The Company has estimated its provision for income taxes in accordance with the Tax Act and guidance available. The Company files U.S. Federal and Florida tax returns that are subject to audit by tax authorities beginning with the year ended December 31, 2012. The Company’s policy is to classify assessments, if any, for tax and related interest and penalties as tax expense.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 8 - COMMITMENTS AND CONTINGENCIES Litigation The Company is subject, from time to time, to litigation, claims and suits arising in the ordinary course of business. On June 21, 2018, Power Up Lending Group Ltd., sued both the Company and four of its managers, ex-managers, and directors of the Company in the United States District Court for the Eastern District of New York. The case was dropped against the Company when Power Up failed to submit a claim in the Company’s Chapter 11 case by the Court Ordered deadline. The claim was discharged by the bankruptcy court upon Plan Confirmation on September 18, 2019. Power Up has continued a tort case against the individuals. The D&O insurance has agreed to cover the CEO Ben Slager, CFO Anthony Santelli, as well as ex-Controller Dennis Lenaburg, in this case. Management believes the Complaint is frivolous and has filed a motion to dismiss which is pending before the Court as of the date of this filing. Leases The Company consolidated its premises into one location on November 1, 2019, and currently leases office and laboratory space in Palm Beach Gardens, FL, that is classified as operating lease right-of-use (“ROU”) assets and operating lease liabilities in the Company’s consolidated balance sheet. ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 months. The lease period is for twenty-four (24) months from November 1, 2019, to October 31, 2021. This had been extended for one year until October 31, 2022. Annual rent commences at $84,100 per annum and increases 3% per year. Tenant is also required to cover operating costs that are estimated at $3,084 per month. Operating lease expense is recognized on a straight-line basis over the lease term and is included in General & Administrative expenses. ASC 842 was effective for us beginning January 1, 2019. The adoption had a material impact on our consolidated balance sheets, but did not have a material impact on our consolidated income statements. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases. Rent expense for the years ending December 31, 2020, and 2019, were $78,825 and $62,239, respectively. The Company recognized the following related to leases in its Consolidated Balance Sheet: YEAR ENDED December 31, 2020 December 31, 2019 Right of Use Lease Liabilities Current portion 80,078 77,746 Long-term portion 72,346 70,240 TOTAL 152,424 147,986 As of December 31, 2020, the total future minimum lease payments in respect of leased premises are as follows: YEAR ENDED MINIMUM DUE 2021 87,056 2022 74,351 2023 0 TOTAL $ 161,407

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 9 – RELATED PARTY TRANSACTIONS Related Transactions The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions. Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. 1) Short-term notes payable, convertible notes, and contingent liabilities issued to related parties are described in NOTE 5. 2) A board resolution was passed on February 13, 2020, that pledged the pending patents to secure the back pay claims of Ben Slager, CEO, Anthony Santelli, CFO, and Charles Sills, Director. This was done to ensure the continued involvement of management to build the Company while they continue to receive less than full salaries. The officers and directors for the Company are involved in other business activities and may, in the future, become involved in other business opportunities. If a specific business opportunity becomes available, such persons may face a conflict in selecting between the Company and their other business interest. The Company has not formulated a policy for the resolution of such conflicts.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 10 – SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date the financial statements were available to be issued. Based on this evaluation, the Company has identified the following subsequent events: Subsequent to December 31, 2020, the Company issued 123,000 shares of common stock for services valued at $21,930, and 100,000 shares of common stock for future services valued at $25,000. Subsequent to December 31, 2020, the Company issued 1,166,667 warrants for services to acquire stock at 15 cents per share. Using a Black-Scholes pricing model, these were valued at $72,090. Subsequent to December 31, 2020, the Company raised $1,935,750 through its private offerings and issued 9,243,332 shares. Subsequent to December 31, 2020, 13,455,009 warrants were executed at an average price of $0.10 per share for total proceeds of $1,302,817. Subsequent to December 31, 2020, 9,913,334 warrants expired. Subsequent to December 31, 2020, 200,000 employee stock options were exercised using the cashless exercise provision to obtain 177,778 shares. Subsequent to December 31, 2020, 350,000 employee stock options were exercised. Subsequent to December 31, 2020, no employee stock options expired. Subsequent to December 31, 2020, the Company issued 20,530,000 employee stock options, of which 10,000 are vested. No additional options vested. Subsequent to December 31, 2020, 10,000 employee stock options vested. Subsequent to December 31, 2020, $274,000 of convertible notes issued during Chapter 11 to related parties and $5,000 of convertible notes issued during Chapter 11 to unrelated parties, converted into 6,980,000 and 100,000 shares of common stock, respectively.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of the Company’s majority-owned subsidiaries over which the Company exercises control.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries, after elimination of intercompany accounts and transactions. Investments in business entities in which the Company lacks control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. All material intercompany transactions and balances were eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates presented and reported amounts of revenues and expenses during the reporting periods presented. Significant estimates inherent in the preparation of the accompanying Consolidated Financial Statements include estimates of impairment assessment of identifiable intangible assets and valuation allowance for deferred tax assets. Estimates are based on past experience and other considerations reasonable under the circumstances. Actual results may differ from these estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents All highly liquid investments with maturities of three months or less at the date of purchase are considered to be cash equivalents.
Stock Compensation	Stock Compensation The Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the provisions of ASC Topic 718, “Stock Compensation” (formerly referred to as SFAS No. 123(R)). Share-based payments to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, ASC Topic 505, “Equity Payments to Non-Employees” or other applicable authoritative guidance.
Stock-based Compensation Valuation Methodology	Stock-based Compensation Valuation Methodology Stock-based compensation resulting from the issuance of common stock is calculated by reference to the valuation of the stock on the date of issuance, the expense being recognized as the compensation is earned. Stock-based compensation expenses related to employee options and warrants granted to non-employees are recognized as the stock options and warrants are earned. The fair value of the stock options or warrants granted is estimated at the grant date, using the Black-Scholes option-pricing model, and the expense is recognized on a straight-line basis over the shorter of the period over which services are to be received or the life of the option or warrant. The grant date fair value of employee share options and similar instruments is estimated using the Black-Scholes option-pricing model on the basis of the fair value of the underlying common stock on the measurement date, adjusted for the unique characteristics of those equity instruments, using the assumptions noted in the table below. The fair value of the common stock is determined by the then-prevailing closing market price. Expected volatility was based on the historical volatility of the Company’s closing day market price per share. The expected term of options and warrants was based upon the life of the option, and the risk-free rate used was based on the U.S. Treasury Daily Yield Curve Rate. The stock compensation issued for services during the years ended December 31, 2020, and December 31, 2019, were valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the years ended December 31, 2020, and December 31, 2019: 2/25/19 3/22/19 5/1/19 5/23/19 5/30/19 7/23/19 7/31/19 Risk-free interest rate 2.48 % 2.24 % 2.52 % 2.31 % 2.03 % 1.83 % 1.84 % Expected life 5 years 5 years 10 years 10 years 5 years 5 years 5 years Expected dividends 0 % 0 % 0 % 0 % 0 % 0 % 0 % Expected volatility 217.76 % 221.85 % 223.38 % 188.70 % 224.24 % 230.08 % 230.30 % ALLM common stock fair value $ 0.020 $ 0.025 $ 0.040 $ 0.050 $ 0.037 $ 0.050 $ 0.050 1/9/20 2/18/20 5/8/20 11/6/20 11/12/20 Risk-free interest rate 1.65 % 1.39 % 0.69 % 0.36 % 0.40 % Expected life 5 years 5 years 10 years 5 years 5 years Expected dividends 0 % 0 % 0 % 0 % 0 % Expected volatility 229.32 % 228.60 % 226.42 % 212.00 % 213.22 % ALLM common stock fair value $ 0.058 $ 0.065 $ 0.083 $ 0.071 $ 0.080
Property and Equipment	Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets, generally 5 to 10 years. Expenditures for additions and improvements are capitalized; repairs and maintenance are expensed as incurred.
Patent Capitalization	Patent Capitalization If a product is currently under research and development and is not currently approved for market, costs incurred in connection with patent applications should generally be expensed in the income statement because there is uncertainty as to the future economic benefit of the asset. Conversely, if a product is approved for market (as is the case of the end product ethanol), or if future economic benefit is probable, or if an alternative future use is available to the Company, then such patent costs can be capitalized and amortized over the expected life of the patent(s). Since the Company’s primary end product is sugar converting to ethanol, which are in wide use, the Company has determined that it is reasonable to capitalize the patent costs associated with its CTS process.
Research and Development	Research and Development The Company expenses all research and development costs as incurred. For the years ended December 31, 2020, and December 31, 2019, the amounts charged to research and development expenses were $763,159 and $797,862, respectively.
Revenue Recognition	Revenue Recognition The Company follows FASB ASC 605 “Revenue Recognition” and recognizes revenue when it is realized or realizable and earned. The Company’s revenues will be derived principally from joint ventures, royalties and eventually corporate owned plants. However, no sales have occurred through those revenue streams to date. The Company considers revenue realized or realizable and earned when all of the following criteria are met: 1. persuasive evidence of an arrangement exists; 2. the product has been shipped or the services have been rendered to the customer; 3. the sales price is fixed or determinable; and, 4. collectability is reasonably assured.
Convertible Instruments	Convertible Instruments The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”. Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company accounts for convertible instruments (when we have determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.
Accounting for Derivative Instruments	Accounting for Derivative Instruments The Company issues debentures where the number of shares into which a debenture can be converted is not fixed. For example, when a debenture converts at a discount to market based on the stock price on the date of conversion. In such instances, the embedded conversion option of the convertible debentures is bifurcated from the host contract and recorded at their fair value. In accounting for derivatives, the Company records a liability representing the estimated present value of the conversion feature considering the historic volatility of the Company’s stock, and a discount representing the imputed interest associated with the beneficial conversion feature. The discount is then amortized over the life of the debenture and the derivative liability is adjusted periodically according to stock price fluctuations. At the time of conversion, any remaining derivative liability is charged to additional paid-in capital. For purposes of determining derivative liability, the Company uses Black-Scholes modeling for computing historic volatility.
Common Stock Purchase Warrants and Other Derivative Financial Instruments	Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
Non-controlling interest in consolidated subsidiaries	Non-controlling interest in consolidated subsidiaries The accompanying consolidated financial statements include the accounts of Alliance BioEnergy Plus, Inc. and those subsidiaries that the Company has the ability to control either through voting rights or means other than voting rights. For these subsidiaries, the Company records 100% of the revenues, expenses, cash flows, assets and liabilities in its consolidated financial statements. For subsidiaries that the Company controls but hold less than 100% ownership, a non-controlling interest is recorded in the consolidated income statement to reflect the non-controlling interest’s share of the net income (loss), and a non-controlling interest is recorded in the consolidated balance sheet to reflect the non-controlling interest’s share of the net assets of the subsidiary. As of the date of this filing, the Company has no subsidiaries.
Investments in non-consolidated affiliates	Investments in non-consolidated affiliates Investments in non-consolidated affiliates are accounted for using the equity method or cost basis depending upon the level of ownership and/or the Company’s ability to exercise significant influence over the operating and financial policies of the investee. When the equity method is used, investments are recorded at original cost and adjusted periodically to recognize the Company’s proportionate share of the investees’ net income or losses after the date of investment. When net losses from an investment are accounted for under the equity method exceed its carrying amount, the investment balance is reduced to zero and additional losses are not provided for. The Company resumes accounting for the investment under the equity method if the entity subsequently reports net income and the Company’s share of that net income exceeds the share of net losses not recognized during the period the equity method was suspended. Investments are written down only when there is clear evidence that a decline in value that is other than temporary has occurred. The Company monitors its investment for impairment at least annually and makes appropriate reductions in the carrying value if it determines that an impairment charge is required based on qualitative and quantitative information. As of the date of this filing, the Company has no investments in non-consolidated affiliates.
Impairment of Long Lived Assets	Impairment of Long Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable, the Company compares the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected to be generated by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the carrying value, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less costs to sell.
Income Taxes	Income Taxes The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized. ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions for any of the reporting periods presented.
Profit (Loss) per Common Share	Profit (Loss) per Common Share: Basic profit (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially dilutive effect of securities such as outstanding options and warrants. The computation of potential common shares has been performed using the treasury stock method. The warrants and options are antidilutive for all periods presented. When net loss is reported, diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive.
Fair Value Measurements	Fair Value Measurements The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions) For the years ended December 31, 2020, and December 31, 2019, the Company recognized a gain of $0 and a gain of $656,533, respectively, on the change in fair value of its derivative liabilities. At December 31, 2020, the Company did not identify any assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with ASC 825-10.
Recent Accounting Pronouncements	Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of Black-scholes Option Pricing Models for Warrant-based Stock Compensation	The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the years ended December 31, 2020, and December 31, 2019: 2/25/19 3/22/19 5/1/19 5/23/19 5/30/19 7/23/19 7/31/19 Risk-free interest rate 2.48 % 2.24 % 2.52 % 2.31 % 2.03 % 1.83 % 1.84 % Expected life 5 years 5 years 10 years 10 years 5 years 5 years 5 years Expected dividends 0 % 0 % 0 % 0 % 0 % 0 % 0 % Expected volatility 217.76 % 221.85 % 223.38 % 188.70 % 224.24 % 230.08 % 230.30 % ALLM common stock fair value $ 0.020 $ 0.025 $ 0.040 $ 0.050 $ 0.037 $ 0.050 $ 0.050 1/9/20 2/18/20 5/8/20 11/6/20 11/12/20 Risk-free interest rate 1.65 % 1.39 % 0.69 % 0.36 % 0.40 % Expected life 5 years 5 years 10 years 5 years 5 years Expected dividends 0 % 0 % 0 % 0 % 0 % Expected volatility 229.32 % 228.60 % 226.42 % 212.00 % 213.22 % ALLM common stock fair value $ 0.058 $ 0.065 $ 0.083 $ 0.071 $ 0.080

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of Notes Payable	A summary of all debts indicated in the Notes above is as follows: Notes Payable December 31, 2020 December 31, 2019 Short Term Notes Payable - Related Party $ - $ Short Term Convertible Debentures Related Party $ 75,000 $ Long Term Chapter 11 Settlement $ 50,000 $ 50,000 Long Term Paycheck Protection Program SBA loan $ 66,330 $ Long Term Notes Payable from future revenue — Related Party $ 1,700,630 $ 1,700,630 Long Term Notes Payable from future revenue — Other $ 120,000 $ 120,000 Long Term Note Payable from future profits — Related Party $ 820,932 $ 820,932 Long Term Note Payable from future profits — Other $ 96,570 $ 96,570 Long Term Convertible Debentures — Related Party $ 204,000 $ 304,000 TOTAL NOTES $ 3,133,462 $ 3,092,132

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Schedule of Option Activity	Stock option activity under the 2012 ESOP for the year ending December 31, 2020, is as follows: Option Shares Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value ($0’s) Outstanding as of December 31, 2019 5,807,099 $ 0.08 6.43 $ 445,815 Awarded 21,550,000 $ 0.10 9.17 $ 2,108,000 Exercised 500,000 $ 0.05 - $ 25,000 Expired 2,900,000 $ 0.09 - $ 257,250 Outstanding as of December 31, 2020 23,957,099 $ 0.09 8.64 $ 2,271,565 Vested as of December 31, 2020 12,707,099 $ 0.09 8.22 $ 1,186,565
Schedule of Warrant Activity	Warrant activity for the year ending December 31, 2020, is as follows: Warrants Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value ($0’s) Outstanding as of December 31, 2019 42,002,390 $ 0.28 3.16 $ 11,693,720 Issued 19,533,333 $ 0.11 0.53 $ 2,180,000 Exercised 6,639,344 $ 0.05 - $ 350,000 Expired 6,255,656 $ 0.09 - $ 554,920 Outstanding as of December 31, 2020 48,640,723 $ 0.23 2.09 $ 11,178,470 Vested as of December 31, 2020 48,640,723 $ 0.23 2.09 $ 11,178,470

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of Reconciliation Between Statutory Tax Rate and Effective Tax Rate	The reconciliation of income tax benefit at the U.S. statutory rate of 21% for years ending December 31, 2020, and 2019, to the Company’s effective tax rate, is as follows: December 31, 2020 December 31, 2019 Statutory federal income tax rate -21 % -21 % State income tax, net of federal benefits -4.46 % -4.46 % Valuation Allowance 25.46 % 25.46 % Income tax provision (benefit) 0 % 0 %
Schedule of Income Tax Provision	The provisional (benefit) for income tax is summarized as follows: December 31, 2020 December 31, 2019 Federal Current - - Deferred $ (458,037 ) $ 211,072 State Current - Deferred $ (97,278 ) $ 44,828 Change in valuation allowance 588,904 (255,900 ) Income tax provision (benefit) - -
Schedule of Tax Effects of Principal Temporary Differences That Give Rise to Deferred Tax Assets	The tax effects of temporary differences that give rise to the Company’s net deferred tax liability as of December 31, 2020 and 2019 are as follows: Years Ended December 31, 2020 December 31, 2019 Deferred tax asset Net operating loss carryovers $ 10,662,231 $ 10,106,916 Total deferred tax assets 10,662,231 10,106,916 Valuation Allowance (10,662,231 ) (10,106,916 ) Deferred tax asset, net of allowance $ - $ -

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of Lease Consolidated Balance Sheet	The Company recognized the following related to leases in its Consolidated Balance Sheet: YEAR ENDED December 31, 2020 December 31, 2019 Right of Use Lease Liabilities Current portion 80,078 77,746 Long-term portion 72,346 70,240 TOTAL 152,424 147,986
Schedule of Future Minimum Lease Payments	As of December 31, 2020, the total future minimum lease payments in respect of leased premises are as follows: YEAR ENDED MINIMUM DUE 2021 87,056 2022 74,351 2023 0 TOTAL $ 161,407

Organization (Details Narrative

Organization (Details Narrative)	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Ownership percentage	100.00%

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital deficiency	$ 766,555
Accumulated losses	$ (6,682,093)	$ (44,500,966)
Market price of products	$ 2.60

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Research and development expenses	$ 763,159	$ 797,862
Ownership percentage	100.00%
Change in fair value of derivative liabilities		$ 656,533
Minimum [Member]
Property and equipment, estimated useful life	5 years
Maximum [Member]
Property and equipment, estimated useful life	10 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Black-Scholes Option Pricing Models for Warrant-based Stock Compensation (Details) - Warrant [Member]	12 Months Ended
	Dec. 31, 2020$ / shares
02/25/2019 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	2.48%
Expected life	5 years
Expected dividends	0.00%
Expected volatility	217.76%
ALLM common stock fair value	$ 0.020
03/22/2019 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	2.24%
Expected life	5 years
Expected dividends	0.00%
Expected volatility	221.85%
ALLM common stock fair value	$ 0.025
05/01/2019 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	2.52%
Expected life	10 years
Expected dividends	0.00%
Expected volatility	223.38%
ALLM common stock fair value	$ 0.040
05/23/2019 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	2.31%
Expected life	10 years
Expected dividends	0.00%
Expected volatility	188.70%
ALLM common stock fair value	$ 0.050
05/30/2019 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	2.03%
Expected life	5 years
Expected dividends	0.00%
Expected volatility	224.24%
ALLM common stock fair value	$ 0.037
07/23/2019 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	1.83%
Expected life	5 years
Expected dividends	0.00%
Expected volatility	230.08%
ALLM common stock fair value	$ 0.050
07/31/2019 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	1.84%
Expected life	5 years
Expected dividends	0.00%
Expected volatility	230.30%
ALLM common stock fair value	$ 0.050
1/9/20 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	1.65%
Expected life	5 years
Expected dividends	0.00%
Expected volatility	229.32%
ALLM common stock fair value	$ 0.058
02/18/2020 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	1.39%
Expected life	5 years
Expected dividends	0.00%
Expected volatility	228.60%
ALLM common stock fair value	$ 0.065
05/08/2020 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	0.69%
Expected life	10 years
Expected dividends	0.00%
Expected volatility	226.42%
ALLM common stock fair value	$ 0.083
11/06/2020 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	0.36%
Expected life	5 years
Expected dividends	0.00%
Expected volatility	212.00%
ALLM common stock fair value	$ 0.071
11/12/2020 [Member]
Warrant Based Stock Compensation [Line Items]
Risk-free interest rate	0.40%
Expected life	5 years
Expected dividends	0.00%
Expected volatility	213.22%
ALLM common stock fair value	$ 0.080

Assets (Details Narrative)

Assets (Details Narrative)	12 Months Ended
	Dec. 31, 2020USD ($)
Patents [Member]
Legal and filing fees	$ 138,016

Debt (Details Narrative)

Debt (Details Narrative) - USD ($)	Mar. 12, 2019	Nov. 08, 2018	Jul. 18, 2018	May 15, 2018	Feb. 28, 2018	Feb. 18, 2018	Jul. 31, 2016	May 31, 2020	Nov. 30, 2017	Jul. 31, 2016	Dec. 31, 2020	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2019	Mar. 27, 2019	May 31, 2018
Notes payable											$ 3,133,462			$ 3,092,132
Equity interest rate											100.00%
Long term convertible debentures											$ 100,000
Remaining due to future revenue											1,820,630
Debt penalty											917,502
Debt amount not discharged or forgiven											2,417,502
Due to related parties											170,000
Due to other											120,000
Note payable to bank											50,000			$ 50,000
Dennis Lenaburg [Member]
Debt due date			Sep. 18, 2022
Payments for settlements			$ 13,650
Claim payable			$ 50,000
Common stock warrants			1,500,000
Warrants strike price			$ 0.30
Warrants term			10 years
Dennis Lenaburg [Member] | Stock Warrants [Member]
Notes payable			$ 2,694,577
Payroll Protection Program [Member]
Debt interest rate								1.00%
Proceeds from loans								$ 66,330			66,330
Debt maturity description								Original maturity date of two years which can be extended to five years
Partiz and Company, P.A [Member] | Maximum [Member]
Principal balance of debt															$ 32,000
Partiz and Company, P.A [Member] | Minimum [Member]
Principal balance of debt															$ 20,000
Small Business Administration [Member]
Forgiveness of debt											$ 66,330
Convertible Debentures [Member] | AES Capital Partners, LP [Member]
Convertible promissory note	$ 50,000
Debt due date	Mar. 12, 2021
Debt instrument term	5 years
Conversion price per share	$ 0.025
Debt interest rate	15.00%
Convertible Debentures [Member] | Edmund J Burke [Member]
Convertible promissory note	$ 25,000	$ 175,000
Debt due date	Mar. 12, 2021
Debt instrument term	5 years
Conversion price per share	$ 0.025	$ 0.05
Debt interest rate		20.00%
Common stock warrants		4,450,148
Warrants strike price		$ 0.005
Warrants expiration date		Nov. 8, 2023
Convertible Debentures [Member] | Edmund J Burke [Member] | Common Stock [Member]
Number of cancelled shares during period		4,450,148
Convertible Debentures [Member] | Chris Jemapete [Member]
Convertible promissory note	$ 25,000
Debt due date	Mar. 12, 2021
Debt instrument term	5 years
Conversion price per share	$ 0.025
Convertible Debentures [Member] | Steven Sadaka [Member]
Convertible promissory note		$ 24,000
Conversion price per share		$ 0.05
Debt interest rate		2.50%
Common stock warrants		1,000,000
Warrants strike price		$ 0.005
Warrants expiration date		Nov. 8, 2023
Convertible Debentures [Member] | Steven Sadaka [Member] | Common Stock [Member]
Number of cancelled shares during period		1,000,000
Convertible Debentures [Member] | Lucas Hoppel [Member]
Debt due date					Sep. 21, 2018				May 30, 2018
Debt interest rate					8.00%				8.00%
Payments for settlements					$ 100,000				$ 100,000
Principal balance of debt					$ 165,000				$ 143,000							$ 40,000
Debt conversion converted instrument shares issued					500,000				500,000
Debt conversion amount					$ 14,500				$ 39,500
Debt discount amount					$ 15,000				$ 43,000
Discount rate					40.00%				35.00%
Debt instrument outstanding, percentage					120.00%				120.00%
Outstanding penalty percentage					40.00%				40.00%
Future gross revenue percentage					5.00%				5.00%
Convertible Debentures [Member] | Annie Bindler [Member]
Convertible promissory note		$ 2,500
Conversion price per share		$ 0.05
Debt interest rate		0.50%
Common stock warrants		100,000
Warrants strike price		$ 0.005
Warrants expiration date		Nov. 8, 2023
Convertible Debentures [Member] | Annie Bindler [Member] | Common Stock [Member]
Number of cancelled shares during period		100,000
Convertible Debentures [Member] | Zac Bindler [Member]
Convertible promissory note		$ 2,500
Conversion price per share		$ 0.05
Debt interest rate		0.50%
Common stock warrants		100,000
Warrants expiration date		Nov. 8, 2023
Convertible Debentures [Member] | Zac Bindler [Member] | Common Stock [Member]
Number of cancelled shares during period		100,000
Short Term Notes Payable [Member]
Debt interest rate							6.00%			6.00%
Remaining acquisition percentage							49.00%			49.00%
Accrued interest							$ 2,002,126					$ 176,460
Plan confirmation description							The renegotiated amounts, as per the Plan Confirmation are all to be paid from 50% of the future net profits and discharged to the extent unpaid five years after the Plan effective date of September 18, 2019.
Debt description											These amount are 1) Mark Koch $240,990 plus 6% interest on any portion not repaid within 12 months of the Company's first reported quarterly net profit; 2) Animated Family Films $579,942 out of the Company's net profits plus 6% interest; 3) Steven Dunkle, CTWC, & Wellington Asset Holdings $1.5 million plus 6% interest once there is positive quarterly EBITDA from the first plant of Company, or, at its option, may convert that into an equity investment in the first plant of the Company, measured by a percentage of the total cost to build, subject to a minimum equity interest of 1.25% in said plant.
Equity interest rate							1.25%			1.25%
Short Term Notes Payable [Member] | Related Party [Member] | AMG Energy Group, LLC [Member]
Debt due date										Aug. 4, 2017
Debt instrument term										5 years
Debt interest rate							6.00%			6.00%
Accrued interest												$ 14,382	$ 8,588
Renegotiated amounts							$ 96,570			$ 96,570
Equity interest rate							49.00%			49.00%
Short Term Loan [Member] | Mark Koch [Member]
Debt interest rate							6.00%			6.00%
Renegotiated amounts							$ 240,990			$ 240,990
Short Term Loan [Member] | Animated Family Films [Member]
Debt interest rate							6.00%			6.00%
Renegotiated amounts							$ 579,942			$ 579,942
Short Term Loan [Member] | Steven Dunkle, CTWC, & Wellington Asset Holdings [Member]
Debt interest rate							6.00%			6.00%
Renegotiated amounts							$ 1,500,000			$ 1,500,000
Short Term Loan [Member] | Steven Sadaka [Member]
Debt due date						May 1, 2018
Principal balance of debt						$ 100,000
Debt conversion converted instrument shares issued						2,000,000
Debt conversion amount						$ 84,000
Debt extended maturity date						Jul. 1, 2018
Short Term Loan [Member] | Steven Sadaka [Member] | Common Stock [Member]
Debt conversion converted instrument shares issued						5,000,000
Debt conversion amount						$ 100,000
Short Term Loan [Member] | Christopher Jemapete [Member]
Debt due date				May 16, 2019
Debt interest rate				5.00%
Common stock warrants				1,000,000
Warrants strike price				$ 0.10
Warrants term				5 years
Accrued interest				$ 315
Renegotiated amounts				50,315
Principal balance of debt				$ 50,000
Debt conversion converted instrument shares issued				1,250,000
Debt conversion amount				$ 36,250
Warrant outstanding value				$ 24,449
Short Term Loan [Member] | Pamela Jemapete [Member]
Debt due date				May 16, 2019
Debt interest rate				5.00%
Common stock warrants				1,000,000
Warrants strike price				$ 0.10
Warrants term				5 years
Accrued interest				$ 315
Renegotiated amounts				50,315
Principal balance of debt				$ 50,000
Debt conversion converted instrument shares issued				1,250,000
Debt conversion amount				$ 36,250
Warrant outstanding value				$ 24,449

Debt - Schedule of Notes Payabl

Debt - Schedule of Notes Payable (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Short Term Notes Payable - Related Party
Short Term Convertible Debentures Related Party	75,000
Long Term Chapter 11 Settlement	50,000	50,000
Long Term Paycheck Protection Program SBA loan	66,330
Long Term Notes Payable from future revenue - Related Party	1,700,630	1,700,630
Long Term Notes Payable from future revenue - Other	120,000	120,000
Long Term Note Payable from future profits - Related Party	820,932	820,932
Long Term Note Payable from future profits - Other	96,570	96,570
Long Term Convertible Debentures - Related Party	204,000	204,000
TOTAL NOTES	$ 3,133,462	$ 3,092,132

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Number of shares authorized	510,000,000
Common stock, shares authorized	500,000,000	500,000,000
Common stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	241,721,947	219,513,233
Common stock, shares outstanding	241,721,947	219,513,233
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Number of shares issued for services, shares	733,130	1,936,450
Number of shares issued for services	$ 37,500	$ 68,472
Number of shares issued, shares	13,558,462
Number of shares issued	$ 887,380	$ 289,000
Number of shares issued debt, shares	1,000,000	100,000
Number of shares issued debt	$ 25,000	$ 5,000
Number of common stock cancelled		49,275,157
Proceeds from exercise from warrants	$ 350,000
Warrants and Stock Option [Member]
Share based payment award options	9,155,656
Employee Stock Option Plan [Member]
Number of shares issued, shares	277,778
Stock option to purchase of common stock shares		8,900,000
Options fair value		$ 220,299
Share based payment award options	500,000
Employee and Directors Stock Option Plan [Member]
Share based payment award options	11,000,000
Value of share based payment award options	$ 876,291
Employee and Directors Stock Option Plan [Member] | Minimum [Member]
Vesting period	5 years
Exercise price	$ 0.042
Employee and Directors Stock Option Plan [Member] | Maximum [Member]
Vesting period	10 years
Exercise price	$ 0.10
Employee and Directors Stock Option Plan [Member] | Unvested Stock Options [Member]
Share based payment award options	10,550,000
Private Offerings [Member]
Number of shares issued, shares		19,436,385
Number of shares issued		$ 934,819
Management and Directors [Member]
Number of shares issued, shares		57,800,000
Number of shares issued		$ 289,000
Warrant [Member]
Number of shares issued for services, shares		2,425,000
Number of shares issued for services		$ 120,084
Warrants and rights outstanding term		5 years
Warrants excerise price per share	$ 0.053	$ 0.05
Number of warrants expired		500,000
Number of shares issued debt, shares		8,500,000
Number of shares issued debt		$ 212,853
Warrants issued	6,639,334
Proceeds from exercise from warrants	$ 350,000

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Option Activity (Details) - Stock Option [Member]	12 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Option Shares Outstanding, Beginning balance | shares	5,807,099
Option Shares Outstanding, Awarded | shares	21,550,000
Option Shares Outstanding, Exercised | shares	500,000
Option Shares Outstanding, Expired | shares	2,900,000
Option Shares Outstanding, Ending balance | shares	23,957,099
Option Shares Outstanding, Vested | shares	12,707,099
Weighted Average Exercise Price, Beginning balance	$ 0.08
Weighted Average Exercise Price, Awarded	0.10
Weighted Average Exercise Price, Exercised	0.05
Weighted Average Exercise Price, Expired	0.09
Weighted Average Exercise Price, Ending balance	0.09
Weighted Average Exercise Price, Vested	$ 0.09
Weighted Average Remaining Contractual Term (years), Beginning balance	6 years 5 months 5 days
Weighted Average Remaining Contractual Term (years), Awarded	9 years 2 months 1 day
Weighted Average Remaining Contractual Term (years), Ending balance	8 years 7 months 21 days
Weighted Average Remaining Contractual Term (years), Vested	8 years 2 months 19 days
Aggregate Intrinsic Value, Beginning balance | $	$ 445,815
Aggregate Intrinsic Value, Awarded	$ 2,108,000
Aggregate Intrinsic Value, Exercised | $	$ 25,000
Aggregate Intrinsic Value, Expired	$ 257,250
Aggregate Intrinsic Value, Ending balance | $	$ 2,271,565
Aggregate Intrinsic Value, Vested | $	$ 1,186,565

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of Warrant Activity (Details) - Warrant [Member]	12 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Warrants Outstanding, Beginning balance | shares	42,002,390
Warrants Outstanding, Issued | shares	19,533,333
Warrants Outstanding, Exercised | shares	6,639,344
Warrants Outstanding, Expired | shares	6,255,656
Warrants Outstanding, Ending balance | shares	48,640,723
Warrants Outstanding, Vested | shares	48,640,723
Weighted Average Exercise Price, Beginning balance | $ / shares	$ 0.28
Weighted Average Exercise Price, Issued | $ / shares	0.11
Weighted Average Exercise Price, Exercised | $ / shares	0.05
Weighted Average Exercise Price, Expired | $ / shares	0.09
Weighted Average Exercise Price, Ending balance | $ / shares	0.23
Weighted Average Exercise Price, Vested | $ / shares	$ 0.23
Weighted Average Remaining Contractual Term (years), Beginning balance	3 years 1 month 27 days
Weighted Average Remaining Contractual Term (years), Issued	6 months 10 days
Weighted Average Remaining Contractual Term (years), Ending balance	2 years 1 month 2 days
Weighted Average Remaining Contractual Term (years), Vested	2 years 1 month 2 days
Aggregate Intrinsic Value, Beginning balance | $	$ 11,693,720
Aggregate Intrinsic Value, Issued | $	2,180,000
Aggregate Intrinsic Value, Exercised | $	350,000
Aggregate Intrinsic Value, Expired | $	554,920
Aggregate Intrinsic Value, Ending balance | $	11,178,470
Aggregate Intrinsic Value, Vested | $	$ 11,178,470

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2017
Reconciliation of income tax benefit U.S.statutory rate	21.00%	21.00%	35.00%
Operating loss carryovers, expiration date	Dec. 31, 2033
Operating loss carryovers, limitations on use	Utilization of the NOLs may be subject to limitation under the Internal Revenue Code Section 382 should there be a greater than 50% ownership change as determined under regulations.
Federal [Member]
Net operating loss carryovers	$ 41,878,363	$ 39,697,236

Income Taxes - Schedule of Reco

Income Taxes - Schedule of Reconciliation Between Statutory Tax Rate and Effective Tax Rate (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Statutory federal income tax rate	(21.00%)	(21.00%)	(35.00%)
State income tax, net of federal benefits	(4.46%)	(4.46%)
Valuation Allowance	25.46%	25.46%
Income tax provision (benefit)	0.00%	0.00%

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Tax Provision (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Federal, Current
Federal, Deferred	(458,037)	211,072
State, Current
State, Deferred	(97,278)	44,828
Change in valuation allowance	588,904	(255,900)
Income tax provision (benefit)

Income Taxes - Schedule of Tax

Income Taxes - Schedule of Tax Effects of Principal Temporary Differences that Give Rise to Deferred Tax Assets (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Net operating loss carryovers	$ 10,662,231	$ 10,106,916
Total deferred tax assets	10,662,231	10,106,916
Valuation Allowance	(10,662,231)	(10,106,916)
Deferred tax asset, net of allowance

Commitments and Contingencies_2

Commitments and Contingencies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Annual rent	$ 78,825	$ 62,239
Operating costs	$ 3,084
Office and Laboratory Space [Member]
Lease description	The lease period is for twenty-four (24) months from November 1, 2019, to October 31, 2021.
Lease extension period	This had been extended for one year until October 31, 2022.
Annual rent	$ 84,100
Percentage of increase in rent per year	3.00%

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Lease Consolidated Balance Sheet (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Right of Use Lease Liabilities Current portion	$ 80,078	$ 77,746
Right of Use Lease Liabilities Long-term portion	72,346	70,240
TOTAL	$ 152,424	$ 147,986

Commitments and Contingencies_3

Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)	Dec. 31, 2019USD ($)
Commitments and Contingencies Disclosure [Abstract]
2021	$ 87,056
2022	74,351
2023	0
TOTAL	$ 161,407

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Apr. 05, 2021	Dec. 31, 2020	Dec. 31, 2019
Number of shares issued for services, shares		733,130	1,936,450
Number of shares issued for services		$ 37,500	$ 68,472
Number of shares issued, shares		13,558,462
Stock Option [Member]
Number of employee stock options exercised		500,000
Stock options vested		12,707,099
Private Offerings [Member]
Number of shares issued, shares			19,436,385
Common Stock [Member]
Number of shares issued for services, shares		733,130	1,936,450
Number of shares issued for services		$ 733	$ 1,936
Number of shares issued, shares			57,800,000
Number of employee stock options exercised		277,778
Warrant [Member]
Number of shares issued for services, shares			2,425,000
Number of shares issued for services			$ 120,084
Warrants issued		6,639,334
Warrants exercise price per share		$ 0.053	$ 0.05
Subsequent Event [Member] | Related Party [Member]
Stock issued during period, value, convertible securities	$ 274,000
Stock issued during period, shares, convertible securities	6,980,000
Subsequent Event [Member] | Unrelated Parties [Member]
Stock issued during period, value, convertible securities	$ 5,000
Stock issued during period, shares, convertible securities	100,000
Subsequent Event [Member] | Stock Option [Member]
Number of shares issued for employee stock options, shares	20,530,000
Stock issued for cashless exercise, shares	10,000
Number of employee stock options exercised	350,000
Stock options expired
Stock options vested	10,000
Subsequent Event [Member] | Employee [Member]
Number of shares issued for employee stock options, shares	200,000
Stock issued for cashless exercise, shares	177,778
Subsequent Event [Member] | Private Offerings [Member]
Proceeds from issuance initial public offering	$ 1,935,750
Number of shares issued, shares	9,243,332
Subsequent Event [Member] | Common Stock [Member]
Number of shares issued for services, shares	123,000
Number of shares issued for services	$ 21,930
Number of common stock for future services issuance, shares	100,000
Number of common stock for future services issuance, value	$ 25,000
Subsequent Event [Member] | Warrant [Member]
Warrants issued	1,166,667
Warrants exercise price per share	$ 15
Value of warrants	$ 72,090
Number of warrants expired	9,913,334
Subsequent Event [Member] | Warrant One [Member]
Warrants issued	13,455,009
Warrants exercise price per share	$ 0.10
Proceeds from warrants	$ 1,302,817